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The human selenoproteome consists of 25 known selenopro-
teins, but functions of many of these proteins are not known. Sel-
enoprotein H (SelH) is a recently discovered 14-kDa mammalian
protein with no sequence homology to functionally characterized
proteins. By sensitive sequence and structure analyses, we identi-
fied SelH as a thioredoxin fold-like protein in which a conserved
CXXUmotif (cysteineseparatedbytwootherresidues fromseleno-
cysteine) corresponds to the CXXC motif in thioredoxins. These
data suggest a redox function of SelH. Indeed, a recombinant SelH
shows significant glutathioneperoxidase activity. Inaddition, SelH
has a conserved RKRK motif in the N-terminal sequence. We
cloned wild-type and cysteine mutant forms of SelH either
upstream or downstream of green fluorescent protein (GFP) and
localized this fusion protein to the nucleus in transfectedmamma-
lian cells, whereas mutations in the RKRK motif resulted in the
cytosolic protein. Interestingly, the full-length SelH-GFP fusion
protein localized specifically to nucleoli, whereas the N-terminal
sequence of SelH fused toGFPhad a diffuse nucleoplasm location.
Northern blot analyses revealed low expression levels of SelH
mRNA in various mouse tissues, but it was elevated in the early
stages of embryonic development. In addition, SelH mRNA was
overexpressed in human prostate cancer LNCaP and mouse lung
cancer LCC1 cells. Down-regulation of SelH by RNA interference
made LCC1 cells more sensitive to hydrogen peroxide but not to
otherperoxides tested.Overall, thesedata establishSelHas anovel
nucleolar oxidoreductase and suggest that some functions in this
compartment are regulated by redox and dependent on the trace
element selenium.
Selenium is an essential trace element with significant bio-
medical potential and roles in human health (1). As a dietary
supplement, selenium has been shown to serve as a cancer che-
mopreventive agent and has roles in immune function, mam-
malian development, male reproduction, and in preventing
heart disease and other cardiovascular and muscle disorders
(for reviews, see Ref. 2). Its biological significance is attributed
to the occurrence of this element in proteins in the form of
selenocysteine (Sec),4 the 21st amino acid in the genetic code
(3). This rare, highly reactive amino acid (4) is encoded by the
UGA codon and is incorporated into proteins co-translation-
ally (5–7). Sec-specific incorporation requires the presence of
cis- and trans-acting elements. In addition toUGA, a stem-loop
structure known as the SECIS (selenocysteine insertion
sequence) element operates as the cis element for Sec incorpo-
ration (8–10). In eukaryotes, SECIS is located in 3-UTRs of
selenoprotein mRNAs and interacts with trans-acting factors.
Recently, an additional recoding element was identified in a
subset of eukaryotic selenoprotein genes that is adjacent to Sec-
encodingUGA codons (11). In eukaryotes, the trans-acting fac-
tors consist of Sec tRNA (12–15), selenocysteyl-tRNA-specific
elongation factor (14, 15), and SBP2 (SECIS-binding protein 2)
(16, 17). These three components function together to redefine
the UGA codon to dictate Sec insertion (6, 18). Ribosomal pro-
tein L30 has also been shown to be a component of the eukary-
otic Sec recoding machinery (19).
Selenoproteins are present in all kingdoms of life, and the full
set of such proteins in a particular organism is known as the
selenoproteome. The human selenoproteome consists of 25
proteins, whereas rodents have 24 such proteins (20). About
half of these proteins (e.g. glutathione peroxidases (21) and thi-
oredoxin reductases (22)) play roles in various redox reactions,
but functions of the remaining selenoproteins are not known.
Therefore, to understand the effects of selenium on human
health and to explain how these effects are governed by dietary
dependence on selenium, the functions of all selenoproteins
need to be elucidated.
Selenoprotein H (SelH) is a recently discovered 14-kDa
mammalian protein with no homology to functionally charac-
terized proteins (20). However, certain similarities to other sel-
enoproteins can be seen, particularly a conserved Cys-Xaa-
Xaa-Sec (CXXU) motif wherein cysteine and Sec are separated
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by two other amino acids. This feature is also present in several
other mammalian selenoproteins (i.e. SelW, SelT, SelM, and
SelV), but the physiological roles of these selenoproteins are
also not known. Structures of SelM (23) and its distant homolog
Sep15 (24) have recently been determined (25). Both proteins
possess a thioredoxin-like domain and reside in the endoplas-
mic reticulum, suggesting that these two proteins are thiol-
disulfide isomerases with a role in disulfide bond formation.
Among other CXXU-containing selenoproteins, SelW is a
better characterized protein, but its function also has not been
defined (26). It is the smallest mammalian selenoprotein exist-
ing in the form of several isoforms that differ by post-transla-
tional modifications (27, 28). SelW is expressed in various tis-
sues and is abundant in muscle. Reduced levels of SelW have
been attributed to white muscle disease (29). SelV is a testis-
specific distant homolog of SelW having an additional domain
of unknown function (20). Herewe used computational,molec-
ular, and cell biology techniques to characterize SelH, which
revealed that this protein is a nucleolar oxidoreductase with an
unusual expression pattern.
EXPERIMENTAL PROCEDURES
Materials—Chemicals were fromSigma, restriction enzymes
from Amersham Biosciences, DNA purification kits from Qia-
gen, and mammalian cell culture reagents from Invitrogen.
Primers used in the study are shown in supplemental Table S1.
Multiple Sequence Alignment, Topology Prediction, and
Structural Motif Search for SelH—All detected SelH sequences
were extracted fromGenBankTM nonredundant and EST data-
bases and analyzed by BLAST (30) and ClustalW software (31).
Localization of SelH was predicted using PSORT II (32). PSI-
BLAST/PHI-BLAST (33) searches with the default setting were
carried out to detect conserved protein domains. The HHpred
web-based program (34) was used for fold prediction.
Recombinant Protein Expression in Escherichia coli andAnti-
body Production—Mouse SelH cDNA clone was purchased
from Research Genetics. The Sec codon was substituted with
that coding for Cys using QuikChange II kit (Stratagene) and
the coding sequence was PCR-amplified and cloned into
pET28a (Novagen). The resulting expression constructwas fur-
ther mutated to obtain CXXS and SXXC variants.
Expression in E. coli BL21 DE3 cells (Novagen) and purifica-
tion of the recombinantHis-tagged protein usingTALONresin
(Clontech) was carried out according to the manufacturer’s
protocols. Rabbit polyclonal antibodies against the recombi-
nant protein were produced by Covance.
Activity Assays—Glutathione peroxidase (GPx) activity was
measured by a coupled reaction with glutathione (35) using
hydrogen peroxide or tert-butyl hydroperoxide (t-BOOH) as
substrates and monitoring the decrease in NADPH absorb-
ance at 340 nm according to the manufacturer’s protocol
(BOIXYTECH GPx-340 assay kit, Oxis Research). The
enzyme unit was defined as the amount of protein needed to
catalyze the oxidation of 1 mol NADPH/min. We assayed
both Cys and Ser mutant forms of recombinant SelH and
used mouse liver lysate as control.
Identification of Target Proteins—Targets of SelH were iden-
tified by trappingmixed disulfides formed between affinity res-
ins containing mutant SelH forms and proteins from a nuclear
fraction of LCC1 cells. The affinity resins were prepared by
cross-linking recombinant SelH proteins (CXXS and SXXC
forms) to N-hydroxysuccinimide ester-activated Sepharose
(GE Healthcare) according to the recommendations of the
manufacturer. Nuclear fraction of LCC1 cells was prepared by
differential centrifugation, homogenized in phosphate-buff-
ered saline (PBS) containing protease inhibitors (Roche
Applied Science), and incubated with SelH-immobilized NHS-
Sepharose resins for 1 h at 25 °C. The resins were extensively
washed with PBS to remove nonspecifically bound proteins.
The resins were then resuspended in 50 mM Tris-HCl, pH 8.0,
200mMNaCl, 10mMdithiothreitol, and incubated for 30min at
25 °C. The eluted sampleswere fractionated by SDS-PAGE, and
proteins were silver-stained. The stained bands were excised
and subjected to liquid chromatography tandem mass spec-
trometry. Data base searches of the acquired tandem mass
spectra were performed using Mascot (Matrix Science, version
1.9.0, London, UK).
Green Fluorescent Protein (GFP) Fusion Constructs—A set of
chimera proteins included SelH fused C- or N-terminally with
GFP. In brief, we amplified wild-type mouse SelH cDNA (con-
struct number 5), prepared its Sec38Cys mutant, and cloned it
into pEGFPN2 and pEGFP-C3 vectors (Clontech).We also pre-
pared a construct by cloning a sequence coding for a 3-kDa
N-terminal portion of SelH upstream of GFP (construct num-
ber 3). A putative nuclear localization signal (NLS) was dis-
rupted by mutating arginines 6 and 8 to serines using the
QuikChange II kit (Stratagene), and for each chimera, the cor-
responding mutant with disrupted NLS was obtained. Trans-
fection of NIH 3T3 cells was performed using Lipofectamine
(Invitrogen), and the images were captured using an Olympus
FV500 inverted focalmicroscope at theUniversity ofNebraska-
Lincoln Microscopy Core Facility.
Immunohistochemistry—NIH 3T3 cells were seeded on cov-
erslips and transfected with SelH-GFP fusion constructs. After
24 h, the cells were washed with PBS and fixed by flashing with
ice-cold methanol containing 0.1% Triton X-100 followed by a
5-min treatment with 4% paraformaldehyde. The cells were
then treated with blocking solution (Roche Applied Science)
and incubated with rabbit anti-nucleolin antibodies (Novus
Biologicals) and mouse monoclonal anti-UB2 antibodies (RDI
Research Diagnostics) concurrently followed by washing with
PBS and treatment with donkey anti-mouse Cy5-conjugated
and monkey anti-rabbit Cy3-conjugated antibodies (Jackson
ImmunoResearch Laboratories). The samples were then
washed with PBS and distilled water and mounted with Gel/
Mount (Biomeda). Dilutions of all commercial antibodies were
as suggested by the manufacturers.
Gene Expression Analyses—An in silico expression analysis
was performed using the SAGE Genie web resource (cgap.
nci.nih.gov/SAGE) (36). Pre-made Northern blot membranes
(mouse adult tissue blot andmouse conceptus embryonic tissue
blot) were purchased from Seegene and probed with 0.3-kb
32P-labeled (Redivue [32P]dCTP, Amersham Biosciences) SelH
cDNA. The probe was generated using the Rediprime II ran-
domprime labeling system (AmershamBiosciences) in accord-
ance with the manufacturer’s protocol. To analyze the expres-
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sion in cell lines, total RNA was isolated using the RNAqueous
kit (Ambion), separated on an agarose gel, transferred onto a
Zeta-Probe blotting membrane (Bio-Rad, protocol from (37)),
and probed as described above.
Western Blot Analyses—Tissues were extracted from eutha-
nizedmice, frozen in liquid nitrogen, and stored at80 °C until
the day of analysis. The tissues were homogenized in PBS con-
taining complete protease inhibitors (Roche Applied Science),
and the lysates were normalized with regard to protein concen-
tration. 10% BisTris NOVEX gels (Invitrogen) were used, and
each well was loaded with 25 g of protein. Following SDS-
PAGE, the proteins were transferred onto polyvinylidene
difluoride membranes (Invitrogen) and probed with anti-
SelH antibodies. Secondary horseradish peroxidase-conju-
gated antibodies were from Amersham Biosciences, and
chemiluminescent peroxidase substrate was from Sigma.
Lysates from various human cancer cell lines (a generous gift
from Dr. Katerina Gurova, Cleveland BioLabs) were exam-
ined as described above.
Cell Culture Labeling, Subcellular Fractionation, and Nucle-
oli Preparation—Experiments involving metabolic labeling of
selenoproteins were carried out by adding 75Se ([75Se]selenious
acid; specific activity 1,000 Ci/mmol, Research Reactor Facility,
University of Missouri, Columbia, MO) to the culture medium
as described previously (38). Separation of cytoplasm and
nuclear fractions was performed as described elsewhere (39). In
brief, following labeling for 48 h, cells were trypsinized, washed
with PBS, homogenized using a tight pestle in 0.25 M sucrose
buffer containing complete protease inhibitor mixture (Roche
Applied Science), and cytosolic and nuclear fractions were sep-
arated by differential centrifugation. The resulting cellular frac-
tions were normalized in regard to protein concentration, sub-
jected to SDS-PAGE, and transferred onto polyvinylidene
difluoridemembrane, and then 75Se-labeled proteinswere visu-
alized with a Storm PhosphorImager system (Amersham Bio-
sciences). Further subfractionation of nuclear compartments to
obtain nucleoli and nucleoplasm fractions was conducted as
described previously (40) with modifications (41).
RNA Interference in LCC1 Cell Line and Oxidative Stress—
To knock down SelH gene expression, five separate 21-nucleo-
tide sequences were selected from SelH cDNA as being unique
using the online service “siDESIGN” of Dharmacon Research,
Inc. These small interfering RNA constructs of pU6-m3 were
prepared as described previously (42). The sequences of all five
SelH small interfering RNA constructs were confirmed. The
five constructs and the pU6-m3 negative control plasmids
were separately transfected into LLC1 cells. After stabilizing
the transfected cells with 0.8 mg/ml hygromycin, SelH mRNA
levels were determined by Northern blot analysis. Based on
mRNA levels, the best small interfering RNA target sequences
of SelH were identified as 5-GAA TTG AAG AAG TAC CTT
TCA-3. These small interfering RNA constructs were used in
subsequent experiments.
Sensitivity of LCC1 cells to oxidative stress was analyzed by
the CellTiter 96 AQueous One Solution cell proliferation assay
(Promega). 5 103 cells were seeded into each well in 96-well
plates and grown overnight in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum. The cells
were washed twice with PBS and incubated in 100 l of serum/
phenol red-freemediumcontaining the indicated (Fig. 6B) con-
centrations of hydrogen peroxide or 0–1 mM t-BOOH, cumyl
hydroperoxide or paraquat for 1 h at 37 °C. To examine sensi-
tivity tomenadione, we used 0–30M treatmentwith this com-
pound for 6 h. 20 l of CellTiter 96 AQueous One Solution rea-
gent were added to each well and incubated for an additional
4 h. The A490 value was recorded using an ELx808 Ultra micro-
plate reader (Bio-Tek Instruments). Cell viability was calcu-
lated as the percentage of untreated controls, and the wells
without cells were used as a blank.
Evolutionary Analysis—Amino acid sequence alignment of
SelH sequences was generated using the PileUP program. The
distances between sequences were calculated from these align-
ments using the DISTANCE program with the Kimura dis-
tance-measuring method, and then the unrooted phylogenetic
tree with unscaled distance branches was generated using the
GrowTree program with the unweighted pair-group method.
All programs were part of the Wisconsin Package, Genetic
Computer Group, Madison, WI (43).
RESULTS ANDDISCUSSION
SelH Is a Putative Nuclear Oxidoreductase—Available SelH
sequences were collected and assembled into amultiple sequence
alignment (Fig. 1A). SelH sequences contain a conserved CXXU
motif, which is flanked upstream by a predicted -strand and
downstream by a predicted -helix. This arrangement is highly
similar to thiol/disulfide oxidoreductases of the thioredoxin
fold; however, the latter proteins have a CXXCmotif instead of
CXXU (44, 45). The use of advanced BLAST programs (PSI-
BLAST/PHI-BLAST) (33) with several iterations revealed a dis-
tant homology to thioredoxin fold proteins. Indeed, further
analysis withHHPred identified a thioredoxin-like fold in SelH.
Structural alignment places the CXXU motif in SelH in the
same place as the CXXC motif in thioredoxin. These data
suggest that SelH is an oxidoreductase that uses its CXXU
motif as the reversible thiolselenol/selenenylsulfide redox
group.
Sequence analysis also revealed nuclear localization signals
(46) in SelH sequences. Remarkably, SelH proteins have a high
content of basic residues (18.3% in mouse and 22.2% in
zebrafish) due to the high occurrence of arginines and lysines.
By using PSORT II, we found six putative NLSs in the SelH
sequences of chickens (all monopartite), three in zebrafish (all
monopartite), and eight in mice and humans (six monopartite
and two bipartite). Comparison of NLS location and conserva-
tions using the multiple sequence alignment showed that only
two NLS were conserved, of which one was in the N-terminal
and one in C-terminal sequences. Within the N-terminal NLS,
the two strictly conserved residues were Arg-6 and Arg-8 (Fig.
1A) (numbering based on the mouse SelH sequence), suggest-
ing that these residues have a critical role in nuclear import as a
part of NLS.
Peroxidase Activity of Recombinant SelH—To further eluci-
date whether SelH is an oxidoreductase, we performed several
biochemical tests with recombinant mutant forms of the pro-
tein in which the Sec residue was substituted with Cys or Ser.
Specifically, these mutants were assayed for thioredoxin, per-
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oxiredoxin, and GPx activities. In the thioredoxin assay, mam-
malian thioredoxin reductase 1 was used as the reductant and
5,5-dithiobis-(2-nitrobenzoic acid) as the oxidant (47, 48), and
a separate assay involved insulin reduction, as in the corre-
sponding assay of thioredoxin function (49). We could detect
no thioredoxin activity of SelH (data not shown). The peroxire-
doxin activity was examined in an assay of protection of gluta-
mine synthetase activity (47). SelH also showed no activity in
this assay. Interestingly, SelHhad a significantGPx activity (Fig.
1B). This activity was detected only with hydrogen peroxide,
whereas t-BOOHwas not active as a substrate. The Cysmutant
had four times higher activity than the Ser mutant of SelH. We
further compared the GPx activity of SelH with that of mam-
malianGPx1 usingmouse liver lysate and quantitativeWestern
blot analysis of GPx1 amounts in the sample (not shown). This
comparison revealed that the GPx activity of the Cys mutant
was 2,000–4,000-fold lower than that of natural mouse liver
GPx1 under the conditions used in the assay. It should be
pointed out that, although SelH had a much lower activity than
GPx1, we assayed the Cys form of the natural Sec-containing
SelH. In addition, the peroxidase activity detected was similar
to the activities of peroxiredoxins in the reduction of hydroper-
oxides. Thus, these data provided further evidence for the oxi-
doreductase activity of SelH. The
natural oxidoreductase activity of
SelH, however, remains unknown,
and further studies will be needed to
identify specific substrates/targets
of this protein.
Identification of Target Proteins—
The finding thatSelHpossesses a thi-
oredoxin fold and has a putative
CXXU redoxmotif suggests analogy
with thioredoxin-like proteins that
form transient disulfides with target
proteins. Mutation of a resolving
Cys in the CXXC motif of thiore-
doxin often results in stabilization
of such complexes (51–53). We uti-
lized this approach to trap the target
proteins of SelH. Affinity resins
were prepared by linking CXXS and
SXXC forms of recombinant SelH
and incubating with a nuclear frac-
tion prepared from LCC1 cells. A
silver-stained gel showing proteins
eluted from the resins is shown in
supplemental Fig. S1. Proteins
enriched on the SelH resins were
then identified by tandem mass
spectrometry sequencing. Among
those detected in the samples were
several thiol oxidoreductases (e.g.
peroxiredoxins 1 and 2, thiore-
doxin, and glutaredoxin), which is
consistent with the redox nature of
interactions between SelH and tar-
get proteins. Interestingly, most
other identified proteins have previously been described as
nucleolar proteins (e.g. pre-mRNA processing protein 8, puta-
tive pre-mRNA splicing factor RNA helicase (DEAH box pro-
tein 15), nucleolin, 60 S ribosomal protein L18, ribosomal pro-
tein S28). It should be noted that the identified proteins should
only be viewed as preliminary targets. Further studies will be
required to functionally characterize these interactions and
determine their specificity.
Localization of SelH-GFP Fusion Constructs—To test
whether SelH is a nuclear protein andwhether Arg-6 andArg-8
are responsible for its location, we prepared and transiently
expressed various SelH-GFP fusion proteins in NIH 3T3 cells
(Fig. 2A). In these experiments, we used a Sec38Cys mutant
form of SelH, which was placed upstream (construct 1) and
downstream (construct 5) of GFP. In addition, we fused a
3-kDa N-terminal portion of the protein that contains the
putative NLS with GFP (construct 3). We also placed a full-
length SelH cDNA sequence including a 3-UTR containing
a SECIS element downstream of GFP as described previously
(20). For each of these four constructs, we developed
mutants in which Arg-6 and Arg-8 were mutated to serines.
Western blot analysis (Fig. 2B) of cells transfected with these
constructs revealed correspondence of the actual sizes of the
FIGURE1.RedoxpropertiesofSelH.A,multiple sequencealignmentof SelH sequences. The locationsofCXXU
(which corresponds to the CXXCmotif in thioredoxins) andNLSmotifs are indicated by boxes, respectively. The
predicted secondary structure is shown above the sequence. B, glutathione peroxidase activity of SelH. The
indicated recombinant formsof SelH (CXXS andCXXC forms) ormouse liver lysatewere assayed forGPx activity
as described under “Experimental Procedures.” Reactions were initiated by adding 300 M H2O2 or 233 M
t-BOOH as the substrate.mU, milliunits.
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FIGURE 2. Localization of SelH. A, organization of SelH-GFP fusion constructs utilized in the localization experiments. SelH was fused either upstream or
downstreamofGFP, and for each construct, the two conserved arginines in theNLSmotifweremutated to serines. In addition, to increase expression levels, Secwas
mutated to Cys in several constructs as shown in the figure. In the constructs expressing a selenoprotein form of SelH, a 3-UTRwas included that contained a SECIS
element. B, detection of SelH-GFP fusion proteins by Western blots using anti-SelH antibodies. Migration of expressed proteins corresponded to their predicted
masses and is indicatedbyarrowson the right. Lanes 1–8 containproteinsgenerated fromthecorrespondingconstructs shown inAabove.C, confocalmicroscopyof
GFP-SelHfusionproteinconstructscontaininganN-terminalSelH.Three imagesareshownforeachconstruct.Leftpanelsshowgreen (GFP) fluorescence,middlepanels
DAPI staining (nuclearmarker), and right panels images obtainedbymerging the left andmiddle panels.Numbering from 1 to 4 corresponds toA above.D, Sameas in
C, except that SelHwas fused downstreamof GFP in the SelH-GFP protein.Numbering from 5 to 8 corresponds to A above.
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fusion proteins to the calculated masses, except for the wild-
type SelH-GFP fusion proteins (constructs 7 and 8 on Fig. 2A
and lanes 7 and 8 on Fig. 2B, respectively), because of signif-
icant premature termination at
the Sec position. Full-length Sec-
containing SelH-GFP fusion pro-
teins were not detectable using
available anti-SelH antibodies.
GFP fluorescence in transfected
cells resulting from SelH-GFP
fusion proteins was determined by
dual wavelength confocal micros-
copy in parallel with a nuclear
marker (DAPI). We found that,
when NLS was present in proteins,
fluorescence was localized to the
nuclear fraction (Fig. 2, C and D;
panels 1, 3, 5, and 7), and when the
arginines weremutated, the fluores-
cence signal was confined to the
cytosol (Fig. 2, C and D; panels 2, 4, 6, and 8). Thus, SelH is a
nuclear protein possessing a RKRK monopartite NLS, and the
arginines in this motif are essential for nuclear targeting of the
protein.
SelH Is a Nucleolar Protein—As shown in Fig. 2, C and D,
fluorescence inside nuclei that reflected localizations of pro-
teins derived from constructs 1, 3, 5, and 7 was heterogeneous.
In fact, both the SelH-GFP andGFP-SelH forms appeared to be
enriched in nucleoli, whereas when only the NLS-containing
N-terminal peptide was fused to GFP (construct 3), fluores-
cence was diffused throughout the nuclear compartment.
Interestingly, in the Sec-containing SelH-GFP fusion protein
(construct 7), which migrated as a 310-kDa protein inWestern
blot assays (Fig. 2B) (indicating significant premature termina-
tion at the UGA codon), the fluorescent signal was not diffused
but still differed from the typical nucleolar staining. We sub-
jected the cells transfected with constructs 1 and 7 to immuno-
histochemical analysis and used markers for nucleolar and
nucleoplasm staining in parallel. As shown in Fig. 3, upper
panel, the full-length SelH co-localizes with nucleolin, a nucle-
olar marker, indicating that SelH is indeed a nucleolar protein.
However, the location of the 3-kDa portion of SelH fused to
GFP (construct 7) was surprising, as it appeared to be present in
the nucleoplasm. Taken together, these data indicate that SelH
is a nucleolar protein and that its correct localization required
the full-length folded protein. The nucleolar location of SelH is
also consistent with the abundance of nucleolar proteins that
were enriched on the SelH resins.
The nucleolus has long been known as a dense subnuclear
structure where ribosome biogenesis occurs (for reviews, see
Refs. 54 and 55). Unlike the nucleus and other membrane-re-
stricted organelles, there is no evidence for the occurrence of a
frontier separating the nucleolus from the surrounding nucle-
oplasm (56, 57). It is thought that anymolecule couldmigrate in
and out of the nucleolus and that targeting of particular cellular
components to the nucleolus depends on interactions with the
co-called nucleolar binding blocks (58).
Expression of SelHmRNA—Toanalyze SelH gene expression,
we initially carried out an in silico expression analysis using
mouse and human expression data that is available in the form
of supplemental Figs. S2 and S3. Both mouse and human SelH
FIGURE 3. SelH is a nucleolar protein. Cells transfected with SelH-GFP (upper panel, construct 1 in Fig. 2) or
GFP-SelH (lower panel, construct 7)weredouble-labeledwith-U2Bantibodies (blue) and-nucleolin antibod-
ies (red). The right image is a merge of the three other images.
FIGURE 4. Expression of SelH during development and in cancer cells.
Northernblot analysis of SelHmRNAexpression is shown.Upper panels inA–C
show SelH expression and lower panels (controls), expression of 28 and 18 S
ribosomal RNAs. Expression during embryonic development (A), in mouse
tissues (B), and in the indicated cells (C) is shown.
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mRNA appeared to bemoderately expressed inmany, if not all,
tissues and organs. However, the majority of expressed
sequence tags were derived from either embryonic or tumor
cells, particularly from carcinomas. Moreover, analysis of
SAGE datasets suggested that expression of human SelH is ele-
vated in some tumors, especially thyroid, lung, stomach, and
liver cancers. In cell lines, SelH appeared high in embryonic
samples, carcinomas, and cell lines derived from bone marrow.
In mouse, it appeared to be elevated in developing brain. Inter-
estingly, we previously found that, during zebrafish develop-
ment, SelH localized within highly proliferative tissues such as
the brain ventricular zone, part of the retina and tectum at 24
hpf, and later in branchial arches and pectoral fin buds and the
proliferative zone of the retina (59). In addition, zebrafish SelH
was identified as essential for embryonic and early larval devel-
opment (60).
To directly examine SelH mRNA expression, we carried out
Northern blot analyses using mouse embryonic and adult tis-
sues and a number of available cell lines (Fig. 4). As expected,we
detected SelH mRNA in various tissues. The signal was partic-
ularly strong in samples from early stages of embryogenesis and
in the adult tissues of thymus, brain, testis, and uterus (Fig. 4, A
and B). In cell lines, SelH mRNA expression was elevated in
LCC1 (lung cancer), LNCaP (human prostate carcinoma),
MCS1 (mouse Sertoli cells), and NIH 3T3 (mouse fibroblasts)
cell lines.
Expression of SelH inMouse Tissues and Human Cancer Cell
Lines—To further elucidate the expression of SelH, we carried
outWestern blot analysis (Fig. 5). SelH was abundant in mouse
spleen but was expressed in lower levels in the brain and was
not detected in the other organs examined (Fig. 5A). In addi-
tion, we analyzed cancer cell lines and found that SelH expres-
sion was dissimilar in various cells, but as expected, it was high
in LNCaP, LCC1, and several other cell lines (Fig. 5B).
We metabolically labeled LNCaP cells with 75Se and then
prepared nuclear and cytoplasmic fractions (Fig. 5C). A 14-kDa
band corresponding in size to SelH was enriched in the nuclear
fraction. The nuclear fraction was further fractionated into
FIGURE5.ExpressionofSelH inmouse tissues.Westernblot analysis of SelH
expression in mouse tissues (A) and indicated cell lines (B) is shown. C, sub-
cellular fractionation of 75Se-labeled LCC1 cells. Note enrichment of thiore-
doxin reductase 1 and GPx1 in the cytosolic fraction, whereas the nuclear
fraction had 14- and 25-kDa selenoproteins. D, SelH localizes specifically to
the nucleolar compartment. Western blot analysis using SelH (upper panel)
and nucleolin (lower panel (control)) is shown. E, direct immunohistochemis-
try of SelH in LCC1 cells.
FIGURE6.SelH-deficientcellsaresensitive tohydrogenperoxidetreatment.
A, verification of knockdown cells. The upper panel shows Northern blot analysis
using the SelH probe,middle panel (control) shows Northern blot analysis using
theGAPDHprobe, and the lower panel showsWestern blot analysis using anti-
SelHantibodies. The left lane shows cells transfectedwith a control vector and
the right lane, SelH knockdown cells. B, viability of control and SelH knock-
down cells treatedwith the indicated concentrations of hydrogenperoxide is
shown.
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nucleolar and nucleoplasm fractions. ByWestern blot analysis,
SelH was detected in the nucleolar fraction, in similar manner
as the control protein nucleolin (Fig. 5D). Subsequent immu-
nohistochemistry analysis further verified the presence of SelH
in nucleoli (Fig. 5E).
Nucleoli are best known as a site for rRNA biosynthesis and
modification. However, nucleoli have additional functions,
such as virus infection control, maturation of non-nucleolar
RNAs and RNPs, regulation of telomerase function and cell
cycle, tumor suppressor and oncogene activities, and cell stress
sensing and signaling (61–63). Moreover, by proteomic
approaches, many uncharacterized proteins have been identi-
fied in nucleoli, suggesting additional unknown functions for
this compartment (41, 64).
RNA Interference of SelH in LCC1 Cells—Because we found
that SelH is a thioredoxin-like protein with significant GPx
activity, this protein was further examined for antioxidant
functions.We employedRNAi to suppress SelH expression and
tested the sensitivity of knockdown cells to oxidative stress.
Decreased expression of SelH in LCC1 knockdown cells was
verified by both Northern andWestern blot analyses (Fig. 6A).
We subjected these cells to treatment with hydrogen peroxide
and found that the knockdown cells were more sensitive to this
form of oxidative stress then control LCC1 cells (Fig. 6B). How-
ever, no difference in sensitivity of knockdown and control cells
was observed when they were treated with tert-butyl hydroper-
oxide (t-BOOH), cumyl hydroperoxide, paraquat, and menadi-
one (data not shown). Higher sensitivity of SelH knockdown
cells to hydrogen peroxide was consistent with a role of this
protein in redox reactions and
observed specificity of SelH for
hydrogen peroxide compared with
t-BOOH.
Nucleoli have been shown to be
involved in oxygen-dependent reg-
ulatory mechanisms via the hypoxi-
a-inducible factor (HIF-1). This
protein is degraded under condi-
tions of normal oxygen tension but
is stabilized in hypoxia by VHL (von
Hippel-Lindau, a tumor suppressor
protein) activating a set of genes
implicated in oxygen homeostasis,
tumor vascularization, and ische-
mic preconditioning (65, 66). It has
been shown that hypoxia can neu-
tralize the function of VHL by trig-
gering its nucleoli sequestration
(67–69). This mechanism under-
lines the importance of redox status
in nucleoli, and we speculate that
SelH, being a nucleolar oxidoreduc-
tase, may play a related role. More-
over, being a selenoprotein, SelH
may mediate certain effects of die-
tary seleniumonnucleolar function.
Evolutionary Analyses—A SelH
phylogenetic tree was constructed
based on the available SelH sequences. As shown in Fig. 7, var-
ious Drosophila species have evolved two additional homologs
of the protein, which form separate branches from the seleno-
protein forms of the protein. Interestingly, additional fruit fly
homologs have neitherCXXCnorCXXUmotifs. Instead, SelH3
possesses a CXXR and SelH2 a CXXT motif, the latter more
typical of peroxiredoxins and glutathione peroxidases, which
are large families of thiol peroxidases involved in various bio-
logical processes (50, 70). These data suggest functional differ-
ences between SelH and the twoDrosophila homologs. It is also
possible that various functions of mammalian SelH are carried
out by separate proteins in fruit flies.
Acknowledgments—We thank Dr. Katerina Gurova for providing
human cancer cell lysates and Anton Turanov for assistance with
thioredoxin activity assays.
REFERENCES
1. Burk, R. F. (2002) Nutr. Clin. Care 5, 75–79
2. Hatfield, D. L., Berry, M. J., and Gladyshev, V. N. (2006) Selenium: Its
Molecular Biology and Role in Human Health, Springer, New York
3. Stadtman, T. C. (1996) Annu. Rev. Biochem. 65, 83–100
4. Johansson, L., Gafvelin, G., and Arner, E. S. (2005) Biochim. Biophys. Acta
1726, 1–13
5. Hatfield, D. L., and Gladyshev, V. N. (2002)Mol. Cell. Biol. 22, 3565–3576
6. Tujebajeva, R.M., Copeland, P. R., Xu, X.M., Carlson, B. A., Harney, J.W.,
Driscoll, D. M., Hatfield, D. L., and Berry, M. J. (2000) EMBO Rep. 1,
158–163
7. Copeland, P. R., and Driscoll, D. M. (2001) Biofactors 14, 11–16
8. Martin, G. W. III, Harney, J. W., and Berry, M. J. (1998) RNA 4, 65–73
FIGURE 7.Phylogenetic analysis of SelH sequences.Animal SelH sequences are split into threebranches, the
major of which is the SelH branch, and the two other groups include fruit fly sequences representing non-
selenoprotein SelH homologs. More distantly related plant sequences have a CXXCmotif. The accession num-
bers (GenBankTM) are as follows: Gallus gallus SelH (46017578), Danio rerio SelH (31342376), Tetradon SelH
(56305185), Anopheles gambiae SelH (27645579),Drosophila melanogaster BthD (14718671), Arabidopsis thali-
ana SelH1 (30689011),Arabidopsis thaliana SelH2 (50058858),Drosophilamelanogaster SelH3 (24584864),Dro-
sophila melanogaster SelH2 (113194556), Mouse SelH (82546880), Rat SelH (109470184), Pig SelH (87230686),
Human SelH (3516960), Ciona savignyi SelH (51695500), Ciona intestinalis SelH (56083593), Drosophila yakuba
SelH3 (84681766), Drosophila simulans SelH3 (61736437), Drosophila yakuba SelH2 (84681627), Drosophila
simulans SelH2 (111276688), Drosophila yakuba BthD (84679567), and Drosophila simulans BthD (61714200).
Characterization of Novel Mammalian Selenoprotein H
APRIL 20, 2007•VOLUME 282•NUMBER 16 JOURNAL OF BIOLOGICAL CHEMISTRY 11967
 at UNIV O
F NEBRASKA - Lincoln on O
ctober 10, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
9. Berry, M. J., Banu, L., Harney, J. W., and Larsen, P. R. (1993) EMBO J. 12,
3315–3322
10. Hubert,N.,Walczak, R., Sturchler, C.,Myslinski, E., Schuster, C.,Westhof,
E., Carbon, P., and Krol, A. (1996) Biochimie (Paris) 78, 590–596
11. Howard, M. T., Aggarwal, G., Anderson, C. B., Khatri, S., Flanigan, K. M.,
and Atkins, J. F. (2005) EMBO J. 24, 1596–1607
12. Diamond, A., Dudock, B., and Hatfield, D. (1981) Cell 25, 497–506
13. Hatfield, D., Diamond, A., and Dudock, B. (1982) Proc. Natl. Acad. Sci.
U. S. A. 79, 6215–6219
14. Amberg, R., Urban, C., Reuner, B., Scharff, P., Pomerantz, S. C., McClos-
key, J. A., and Gross, H. J. (1993) Nucleic Acids Res. 21, 5583–5588
15. Park, S. I., Park, J. M., Chittum, H. S., Yang, E. S., Carlson, B. A., Lee, B. J.,
and Hatfield, D. L. (1997) Biomed. Environ. Sci. 10, 116–124
16. Low, S. C., Grundner-Culemann, E., Harney, J. W., and Berry, M. J. (2000)
EMBO J. 19, 6882–6890
17. Copeland, P. R., Fletcher, J. E., Carlson, B. A., Hatfield, D. L., and Driscoll,
D. M. (2000) EMBO J. 19, 306–314
18. Copeland, P. R. (2003) Gene 312, 17–25
19. Chavatte, L., Brown, B. A., andDriscoll, D.M. (2005)Nat. Struct.Mol. Biol.
12, 408–416
20. Kryukov, G. V., Castellano, S., Novoselov, S. V., Lobanov, A. V., Zehtab,
O., Guigo, R., and Gladyshev, V. N. (2003) Science 300, 1439–1443
21. Aumann, K. D., Bedorf, N., Brigelius-Flohe, R., Schomburg, D., and Flohe,
L. (1997) Biomed. Environ. Sci. 10, 136–155
22. Arner, E. S., and Holmgren, A. (2000) Eur. J. Biochem. 267, 6102–6109
23. Korotkov, K. V., Novoselov, S. V., Hatfield, D. L., and Gladyshev, V. N.
(2002)Mol. Cell. Biol. 22, 1402–1411
24. Korotkov, K. V., Kumaraswamy, E., Zhou, Y., Hatfield, D. L., and Glady-
shev, V. N. (2001) J. Biol. Chem. 276, 15330–15336
25. Ferguson, A. D., Labunskyy, V. M., Fomenko, D. E., Arac, D., Chelliah, Y.,
Amezcua, C. A., Rizo, J., Gladyshev, V. N., and Deisenhofer, J. (2006)
J. Biol. Chem. 281, 3536–3543
26. Whanger, P. D. (2000) CMLS Cell. Mol. Life Sci. 57, 1846–1852
27. Beilstein, M. A., Vendeland, S. C., Barofsky, E., Jensen, O. N., and
Whanger, P. D. (1996) J. Inorg. Biochem. 61, 117–124
28. Gu, Q. P., Beilstein, M. A., Barofsky, E., Ream, W., and Whanger, P. D.
(1999) Arch. Biochem. Biophys. 361, 25–33
29. Gu, Q. P., Sun, Y., Ream, L. W., and Whanger, P. D. (2000) Mol. Cell.
Biochem. 204, 49–56
30. Altschul, S. F., Gish,W.,Miller,W.,Myers, E.W., and Lipman, D. J. (1990)
J. Mol. Biol. 215, 403–410
31. Thompson, J. D., Higgins, D.G., andGibson, T. J. (1994)Nucleic Acids Res.
22, 4673–4680
32. Nakai, K., and Horton, P. (1999) Trends Biochem. Sci. 24, 34–36
33. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller,
W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389–3402
34. Soding, J., Biegert, A., and Lupas, A. N. (2005) Nucleic Acids Res. 33,
W244–W248
35. Paglia, D. E., and Valentine, W. N. (1967) J. Lab. Clin. Med. 70, 158–169
36. Boon, K., Osorio, E. C., Greenhut, S. F., Schaefer, C. F., Shoemaker, J.,
Polyak, K.,Morin, P. J., Buetow, K. H., Strausberg, R. L., De Souza, S. J., and
Riggins, G. J. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 11287–11292
37. Sambrook, J., Fritsch, E. F., and Maniatis, T. (eds) (1989)Molecular Clon-
ing, A Laboratory Manual. 2nd Ed., pp. 16.33–16.37, Cold Spring Harbor
Laboratory Press, New York
38. Kryukov, G. V., Kryukov, V.M., and Gladyshev, V. N. (1999) J. Biol. Chem.
274, 33888–33897
39. Berrios, M. (1997) Nuclear Structure and Function (Methods in Cell Biol-
ogy), pp. 6–15, Academic Press, New York
40. Busch, H., Muramatsu, M., Adams, H., Steele, W. J., Liau, M. C., and
Smetana, K. (1963) Exp. Cell Res. 24, Suppl. 9, 150–163
41. Andersen, J. S., Lam, Y. W., Leung, A. K., Ong, S. E., Lyon, C. E., Lamond,
A. I., and Mann, M. (2005) Nature 433, 77–83
42. Xu, X.M.,Mix,H., Carlson, B. A., Grabowski, P. J., Gladyshev, V.N., Berry,
M. J., and Hatfield, D. L. (2005) J. Biol. Chem. 280, 41568–41575
43. Senger, M., Flores, T., Glatting, K., Ernst, P., Hotz-Wagenblatt, A., and
Suhai, S. (1998) Bioinformatics (Oxf.) 14, 452–457
44. Martin, J. L. (1995) Structure (Lond.) 3, 245–250
45. Kinch, L. N., Baker, D., and Grishin, N. V. (2003) Proteins 52, 323–331
46. Hicks, G. R., and Raikhel, N. V. (1995) Annu. Rev. Cell Dev. Biol. 11,
155–188
47. Kim, K., Kim, I. H., Lee, K. Y., Rhee, S. G., and Stadtman, E. R. (1988) J. Biol.
Chem. 263, 4704–4711
48. Krause, G., and Holmgren, A. (1991) J. Biol. Chem. 266, 4056–4066
49. Bjornstedt, M., Hamberg, M., Kumar, S., Xue, J., and Holmgren, A. (1995)
J. Biol. Chem. 270, 11761–11764
50. Rhee, S. G., Kang, S. W., Jeong, W., Chang, T. S., Yang, K. S., and Woo,
H. A. (2005) Curr. Opin. Cell Biol. 17, 183–189
51. Holmgren, A., Johansson, C., Berndt, C., Lonn, M. E., Hudemann, C., and
Lillig, C. H. (2005) Biochem. Soc. Trans. 33, 1375–1377
52. Fernandes, A. P., and Holmgren, A. (2004) Antioxid. Redox Signal. 6,
63–74
53. Motohashi, K., Kondoh, A., Stumpp, M. T., and Hisabori, T. (2001) Proc.
Natl. Acad. Sci. U. S. A. 98, 11224–11229
54. Granneman, S., and Baserga, S. J. (2005)Curr. Opin. Cell Biol. 17, 281–286
55. Raska, I., Shaw, P. J., and Cmarko, D. (2006) Curr. Opin. Cell Biol. 18,
325–334
56. Jacobson, M. R., Cao, L. G., Wang, Y. L., and Pederson, T. (1995) J. Cell
Biol. 131, 1649–1658
57. Shaw, P. J., and Jordan, E. G. (1995) Annu. Rev. Cell Dev. Biol. 11, 93–121
58. Carmo-Fonseca, M., Mendes-Soares, L., and Campos, I. (2000) Nat. Cell
Biol. 2, E107–E112
59. Thisse, C., Degrave, A., Kryukov, G. V., Gladyshev, V. N., Obrecht-Pflu-
mio, S., Krol, A., Thisse, B., and Lescure, A. (2003) Gene Expr. Patterns 3,
525–532
60. Amsterdam, A., Nissen, R. M., Sun, Z., Swindell, E. C., Farrington, S., and
Hopkins, N. (2004) Proc. Natl. Acad. Sci. U. S. A. 101, 12792–12797
61. Olson, M. O., Hingorani, K., and Szebeni, A. (2002) Int. Rev. Cytol. 219,
199–266
62. Pederson, T. (1998) Nucleic Acids Res. 26, 3871–3876
63. Handwerger, K. E., and Gall, J. G. (2006) Trends Cell Biol. 16, 19–26
64. Scherl, A., Coute, Y., Deon, C., Calle, A., Kindbeiter, K., Sanchez, J. C.,
Greco, A., Hochstrasser, D., and Diaz, J. J. (2002) Mol. Biol. Cell 13,
4100–4109
65. Maxwell, P. H., Wiesener, M. S., Chang, G.W., Clifford, S. C., Vaux, E. C.,
Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., and Ratcliffe,
P. J. (1999) Nature 399, 271–275
66. Jaakkola, P., Mole, D. R., Tian, Y. M., Wilson, M. I., Gielbert, J., Gaskell,
S. J., Kriegsheim, A., Hebestreit, H. F., Mukherji, M., Schofield, C. J., Max-
well, P. H., Pugh, C. W., and Ratcliffe, P. J. (2001) Science 292, 468–472
67. Mekhail, K., Khacho, M., Carrigan, A., Hache, R. R., Gunaratnam, L., and
Lee, S. (2005) J. Cell Biol. 170, 733–744
68. Mekhail, K., Khacho, M., Gunaratnam, L., and Lee, S. (2004) Cell Cycle 3,
1027–1029
69. Mekhail, K., Gunaratnam, L., Bonicalzi, M. E., and Lee, S. (2004)Nat. Cell
Biol. 6, 642–647
70. Hofmann, B., Hecht, H. J., and Flohe, L. (2002) Biol. Chem. 383, 347–364
Characterization of Novel Mammalian Selenoprotein H
11968 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 282•NUMBER 16•APRIL 20, 2007
 at UNIV O
F NEBRASKA - Lincoln on O
ctober 10, 2007 
w
w
w
.jbc.org
D
ow
nloaded from
 
 23 
Supplementary data 
 
 
Table S1. Primers used in the study.  
1. Primers used for mutating CxxU motif 
Forward_CxxC -5’-GCATTGTACGAGCTGTCGCGTGTACGGCCGCCATGC-3’ 
Reverse_CxxC -5’-GCATGGCGGCCGTACACGCGACAGCTCGTACAATGC-3’ 
Forward_CxxS -5’-GCATTGTACGAGCTCACGCGTGTACGGCCGCCATGC-3’ 
Reverse_CxxS -5’-GCATGGCGGCCGTTGACGCGACAGCTCGTACAATGC-3’ 
Forward_SxxC -5’-CCGTGGTCATTGAGCATAGTACGAGCTGTCGCGTGTAC3’ 
Reverse_SxxC -5’-CCGTACACGCGACAGCTCGTACTATGCTCAATGACCAC3’ 
2. Primers used to mutate arginines 6 and 8 to serines: 
ATGGCCCCCCACGGAAGTAAGAGTAAGGCGGGGGCCGCG 
CGCGGCCCCCGCCTTACTCTTACTTCCGTGGGGGGCCAT 
3. Primers used for cloning into pET: 
Forward -5’-TAAACGA CATATGGCCCCCCACGGAAG AAAG-3’ 
Reverse -5’-CTACC'TCGAGTTATGAAAGGTACTTCTTCAATTC-3’ 
4. Primers used for cloning into pEGFP-N2: 
Forward -5’-CTAAGAATTC ATGGCCCCCCACGGAAGAAAG-3’ 
Reverse 1 -5’-CGTAGGATCCATGAAAGGTACTTCTTCAATTCTTCAACC-3’ 
Reverse 2 -5’-CGTAGGATCCTCGCGCCCTCCGCCAGTTTCTC-3’ 
5. Primers used for cloning into pEGFP-C3: 
Forward -5’-CTACCTCGAGTTATGAAAGGTACTTCTTCAATTC-3’ 
Reverse 1 -5’-GCAAGGATCCGAAACACTTTTACAATGTCTTGC-3’ 
Reverse 2 -5’-CTACC'TCGAGTTATGAAAGGTACTTCTTCAATTC-3’ 
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Fig. S1 
 
 
Fig. S1. Identification of SelH target proteins in LCC1 cells. This silver stained SDS PAGE 
gel shows nuclear proteins from LCC1 cells enriched on SxxC-SelH and SxxC-SelH resins. Due 
to close similarity of targets identified in each of the variants, the targets are labeled only for one 
mutant. Migration of molecular weight standards is shown on the right. The following proteins 
were identified by MS/MS sequencing of protein bands extracted from the gel: 1 - pre-mRNA 
processing  protein 8, 2 - putative pre-mRNA splicing factor RNA helicase (DEAH box protein 
15), 3 - nucleolin, 4 - nuclear cap binding protein subunit 1, 5 - PTB-associated splicing factor, 6 
- heterogeneous nuclear ribonucleoprotein R, 7 - IGF-II mRNA-binding protein 2, 8 - nucleolar 
protein, 9 - glyoxylate reductase/hydroxypyruvate reductase, 10 - poly(rC) binding protein 1 and 
heterogeneous nuclear ribonucleoprotein X, 11 - Rbbp5 protein, 12 - spliceosome-associated 
protein SAP 62, 13 - nucleophosmin 1 and nucleolar protein NO38, 14 - heterogeneous nuclear 
ribonucleoprotein A1 (helix-destabilizing protein), 15 - peroxiredoxin 1, natural killer-enhancing 
factor A and proliferation-associated gene, 16 - peroxiredoxin 2, 17 -60S ribosomal protein L18, 
18 - glutaredoxin, 19 - thioredoxin 1, and 20 - ribosomal protein S28. 
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Fig. S2. Computational analysis of SelH mRNA expression profiles using publicly available 
expression data. A. GeneNote database contains data on whole genome mRNA expression 
profiles in normal human tissues. Two organs that showed the highest SelH mRNA levels in 
humans are thymus and spleen. B. Gene Atlas database contains data on whole genome mRNA 
expression profiles in normal human and mouse tissues. Similar to human, two organs with the 
highest SelH mRNA levels in mouse are thymus and spleen. 
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Fig. S3 
 
 
Library Total Tags in 
Library 
SelH Tags per 
200,000 
Embryonic stem cell HES3 normal p16 CL SHE10 205353 105 
Bone marrow normal AP CD34+/CD38-/lin- 86391 90 
Embryonic stem cell H9 normal p38 CL SHES1 151735 90 
Embryonic stem cell H1 normal p54 CL SHE16 218214 82 
Liver cholangiocarcinoma B K2D 46853 76 
Breast carcinoma CL ZR75 1 untreated 32303 74 
Bone marrow normal AP CD34+/CD38+/lin+ 81595 73 
Breast carcinoma CL MCF7 control 0h 59877 73 
Emryonic stem cell H14 normal p22 CL SHE14 212170 73 
Lung adenocarcinoma B 1 36256 71 
Colon carcinoma CL Hct116 wildtype p53 Normal 
Oxygen 
80398 69 
Prostate carcinoma CL LNCaP-T 43542 68 
Colon carcinoma CL Hct116 p53 knockout Anoxia 79053 65 
Pancreas carcinoma CL ASPC 31224 64 
 
 
Fig. S3. SAGE Genie in silico expression analysis of SelH expression. 
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